Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.8%
5Y CAGR+37.7%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+11.8%/yr
Annual compound
5Y CAGR
+37.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$90.61M+34.2%
2024$67.53M+5.3%
2023$64.16M-0.9%
2022$64.76M+17.2%
2021$55.27M+202.5%
2020$18.27M-